MEADOWVIEW BIOLOGICAL RESEARCH STATION (EIN 541904513) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1998

Legal Domicile

Principal Officer

PHIL SHERIDAN

Phone

8046334336

Tax Period

2025-01-01 to 2025-12-31

MEADOWVIEW BIOLOGICAL RESEARCH STATION, founded in 1998, is a small nonprofit in the Science & Technology sector that reported $165K in total revenue in fiscal year 2018. Revenue grew 11% year-over-year, indicating healthy expansion. The organization ran a surplus of $29K, a strong 18% operating margin.

Mission

PRESERVING AND RESTORING RARE WETLAND PLANTS AND THEIR ASSOCIATED HABITATS ON THE COASTAL PLAIN OF MARYLAND AND VIRGINIA

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $76,719

Program Service Revenue $0

Investment Income $2,711

Other Revenue $0

TOTAL REVENUE $79,430

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,384

Fundraising Expenses $0

Program Expenses $111,359

Other Expenses $109,975

TOTAL EXPENSES $111,359

Year-over-Year Comparison

	2025	2024	Change
Revenue	$79,430	$98,457	-0.2%
Expenses	$111,359	$157,932	-0.3%
Net Income	$-31,929	$-59,475	-0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DR PHIL SHERIDAN	DIRECTOR/PRESIDENT	40.00	Officer Director Key Emp	$0	$0	$0
CHASE HOWARD	DIRECTOR	3.00	Director	$0	$0	$0
DR ROBERT WRIGHT	DIRECTOR	3.00	Director	$0	$0	$0
MR HAMMOND	BOARD MEMBER	20.00	Director	$0	$0	$0
MR WHITEHEAD	BOARD MEMBER	3.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$79,430	$111,359	$1,797,559	$-31,929
2024	No data	No data	No data	No data
2023	$93,003	$154,149	$1,885,815	$-61,146
2022	$307,955	$164,552	$2,003,759	$143,403
2021	$311,571	$123,784	$1,912,361	$187,787
2020	$305,124	$80,366	$1,385,417	$224,758
2019	$141,380	$83,604	$849,733	$57,776
2018	$165,108	$135,660	$830,797	$29,448

MEADOWVIEW BIOLOGICAL RESEARCH STATION